This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bates, B Articles by Goldfarb, M Search for Related Content PubMed PubMed Citation Articles by Bates, B Articles by Goldfarb, M

 Previous Article  |  Next Article 

Mol Cell Biol. 1991 April; 11(4): 1840-1845

Biosynthesis of human fibroblast growth factor-5.

Department of Biochemistry and Molecular Biophysics, Columbia University College of Physicians and Surgeons, New York, New York 10032.

ABSTRACT

We have analyzed the biosynthesis of human fibroblast growth factor-5 (FGF-5) at the translational and posttranslational levels. FGF-5 RNA synthesized in vitro can be translated in rabbit reticulocyte lysates to yield a 29,500-Da protein, which is consistent with the molecular weight predicted from the coding sequence. The efficiency of FGF-5 translation is dramatically enhanced if an upstream open reading frame (ORF-1) in the RNA is deleted or if both AUG codons in ORF-1 are destroyed by point mutations, while partial enhancement is achieved by individual mutation of either ORF-1 AUG codon. These data suggest that FGF-5 synthesis requires the scanning of ribosomes past the two ORF-1 AUG codons. The introduction of these ORF-1 mutations into a eukaryotic FGF-5 expression vector increases its capacity to transform mouse NIH 3T3 cells up to 50-fold upon transfection. FGF-5 is secreted from transfected 3T3 cells and from human tumor cells as glycoproteins containing heterogeneous amounts of sialic acid. Glycosidase treatments suggest that the growth factor bears both N-linked and O-linked sugars.

This article has been cited by other articles:

• Lu, S. Y., Sontag, D. P., Detillieux, K. A., Cattini, P. A. (2008). FGF-16 is released from neonatal cardiac myocytes and alters growth-related signaling: a possible role in postnatal development. Am. J. Physiol. Cell Physiol. 294: C1242-C1249 [Abstract] [Full Text]  
• Gereben, B., Kollar, A., Harney, J. W., Larsen, P. R. (2002). The mRNA Structure Has Potent Regulatory Effects on Type 2 Iodothyronine Deiodinase Expression. Mol. Endocrinol. 16: 1667-1679 [Abstract] [Full Text]  
• Kozak, M. (2001). Constraints on reinitiation of translation in mammals. Nucleic Acids Res 29: 5226-5232 [Abstract] [Full Text]  
• Hanada, K.-i., Perry-Lalley, D. M., Ohnmacht, G. A., Bettinotti, M. P., Yang, J. C. (2001). Identification of Fibroblast Growth Factor-5 as an Overexpressed Antigen in Multiple Human Adenocarcinomas. Cancer Res. 61: 5511-5516 [Abstract] [Full Text]  
• Ozawa, K., Suzuki, S., Asada, M., Tomooka, Y., Li, A.-J., Yoneda, A., Komi, A., Imamura, T. (1998). An Alternatively Spliced Fibroblast Growth Factor (FGF)-5 mRNA Is Abundant in Brain and Translates into a Partial Agonist/Antagonist for FGF-5 Neurotrophic Activity. J. Biol. Chem. 273: 29262-29271 [Abstract] [Full Text]  
• Ishiwata, T, Kornmann, M, Beger, H G, Korc, M (1998). Enhanced fibroblast growth factor 5 expression in stromal and exocrine elements of the pancreas in chronic pancreatitis. Gut 43: 134-139 [Abstract] [Full Text]  
• Lazaris-Karatzas, A, Smith, M R, Frederickson, R M, Jaramillo, M L, Liu, Y L, Kung, H F, Sonenberg, N (1992). Ras mediates translation initiation factor 4E-induced malignant transformation.. Genes Dev. 6: 1631-1642 [Abstract]